May 4, 2026 08:00AM
Aug 4, 2025 08:00AM
Mar 10, 2025 04:05PM
Feb 11, 2025 08:00AM
Nov 14, 2024 04:01PM
Mar 7, 2024 04:01PM
Feb 13, 2024 08:01AM Lineage (LCTX) Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
Feb 13, 2024 08:00AM
Dec 18, 2023 08:05AM
Dec 18, 2023 08:00AM
Nov 9, 2023 04:01PM
Aug 10, 2023 04:01PM
May 11, 2023 04:01PM
Mar 9, 2023 04:01PM Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Feb 8, 2023 08:05AM
Feb 8, 2023 08:00AM
Nov 29, 2022 08:00AM
Nov 28, 2022 08:00AM
Nov 10, 2022 04:05PM
Oct 10, 2022 08:00AM
Aug 11, 2022 04:05PM Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
May 12, 2022 04:05PM
May 3, 2022 08:01AM
May 3, 2022 08:00AM
Apr 13, 2022 08:00AM
Mar 24, 2022 04:27PM
Mar 21, 2022 08:00AM
Mar 14, 2022 08:00AM RG6501 (OpRegen®) Full Phase 1/2a Results to Be Featured at 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Allen C. Ho, M.D., FACS
Mar 10, 2022 04:05PM
Nov 30, 2021 08:00AM
Nov 15, 2021 08:00AM
Nov 10, 2021 04:05PM
Oct 26, 2021 08:00AM
Sep 30, 2021 10:53AM
Sep 30, 2021 10:52AM Promising New OpRegen® Clinical Data Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.
Sep 15, 2021 09:05AM
Sep 15, 2021 09:00AM
Aug 12, 2021 04:05PM
Jul 20, 2021 08:08AM
Jul 20, 2021 08:00AM
Jun 22, 2021 10:45AM
Jun 22, 2021 06:50AM Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury to Return to Clinical Testing
Jun 3, 2021 08:00AM
May 13, 2021 04:05PM
Apr 12, 2021 08:00AM
Mar 31, 2021 09:22AM
Mar 30, 2021 05:42PM
Mar 23, 2021 08:03AM
Mar 23, 2021 08:00AM Lineage Cell Therapeutics Presents Additional Interim Data on OpRegen® for Dry AMD With Geographic Atrophy
Mar 11, 2021 04:05PM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All